title: Methylphenidate-induced autoimmune hepatitis.
authors.affiliation: Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA. jjl8v@virginia.edu
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Lewis
authors.forename: Julia C
authors.initials: JC
authors.lastname: Iezzoni
authors.forename: Carl L
authors.initials: CL
authors.lastname: Berg
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003863:Depression / Q000188:drug therapy; D019693:Hepatitis, Autoimmune / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin